Literature DB >> 16507274

Marginal zone lymphoma.

Omid S Shaye1, Alexandra M Levine.   

Abstract

Marginal zone lymphomas (MZLs) comprise 3 distinct entities: extranodal MZL of mucosa-associated lymphoid tissue (MALT), splenic MZL, and nodal MZL. Gastric MALT lymphoma is the most common extranodal MZL and often develops as a result of chronic Helicobacter pylori gastritis. Such cases frequently respond to antibiotics directed against H. pylori. Antigen-driven lymphomatous disease can also be seen in the association of Borrelia burgdorferi with MALT lymphoma of the skin, Chlamydia psittaci with MALT lymphoma of the ocular adnexa, Campylobacter jejuni with immunoproliferative disease of the small intestine, and hepatitis C with splenic MZL. This article discusses the pathogenesis and clinical features of MZL and the treatment options available to patients.

Entities:  

Mesh:

Year:  2006        PMID: 16507274     DOI: 10.6004/jnccn.2006.0026

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  4 in total

1.  A case of mucosa-associated lymphoid tissue lymphoma of the sigmoid colon presenting as a semipedunculated polyp.

Authors:  Myung Hwan Kim; Jin Tae Jung; Eui Jung Kim; Tae Won Kim; Seon Young Kim; Joong Goo Kwon; Eun Young Kim; Woo Jung Sung
Journal:  Clin Endosc       Date:  2014-03-31

Review 2.  Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Colon: A Case Report and a Literature Review.

Authors:  Hafsa Abbas; Masooma Niazi; Jasbir Makker
Journal:  Am J Case Rep       Date:  2017-05-04

3.  Magnetic Resonance Imaging-Guided Radiation Therapy for Early-Stage Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.

Authors:  Neris Dincer; Gamze Ugurluer; Gorkem Gungor; Teuta Zoto Mustafayev; Banu Atalar; Enis Ozyar
Journal:  Cureus       Date:  2022-09-11

4.  Treatment of splenic marginal zone lymphoma of the CNS with high-dose therapy and allogeneic stem cell transplantation.

Authors:  Christoph Busemann; Andrej Gudzuhn; Carsten Hirt; Michael Kirsch; Silke Vogelgesang; Christian A Schmidt; Gottfried Dölken; William H Krüger
Journal:  Exp Hematol Oncol       Date:  2012-10-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.